Science agrees with Scoot, the travel bug really does exist!
Scoot, Singapore-based long-haul low-cost carrier, is partnering with world-renowned expert in Genetics, Human Biology and Neuroscience, Dr. Richard Paul Ebstein of the National University of Singapore, to prove how travel is embedded in our blood. Engaging Scoot employees and consumers alike, the airline is embarking on an industry-first experiment to prove that travel is an innate human need – and not just a want – something Scoot refers to as Wandermust.
“With the Wandermust Experiment, our goal is to use science to show that travel is an intrinsic need, rather than just a luxury. By gaining deeper insights into the preferences and habits of our customers, we can continue working toward our goal of making travel attainable for everyone,” says Lee Lik Hsin, Chief Executive Officer of Scoot. “This partnership with Dr. Ebstein also reinforces our commitment to continuously empower consumers so they can fully embrace their Wandermust.”
As more and more consumers embrace their need to travel, Scoot understands that this has also brought about the recent day trend of people, especially young people, being criticised or judged for travelling “too much”.
As part of the experiment, Dr. Ebstein, who has extensively studied the DRD4-7R gene (carried by approximately 20 percent of the population) and its link to novelty-seeking behaviours such as traveling, will specifically look into the role of genetics as well as the impact of cultural influences.
Find out if travel is in your blood
To uncover the truth about Wandermust, Scoot is looking for ardent travellers who are willing to volunteer to be part of this scientific experiment. Aside from discovering whether travel is in their blood, participants also stand a chance to win 100,000 KrisFlyer miles – all the better to indulge their Wandermust with!
To learn more about this experiment, watch Dr. Ebstein explain it here: https://www.facebook.com/FlyScootAU/videos/1492989957479360/
“I’m excited to hear from the seasoned travellers from around the world – to understand their nature and prove their innate need to travel through the Wandermust Experiment,” said Dr. Richard Paul Ebstein. “It’s encouraging to see that an airline like Scoot is leading the way in proving how travel is in our blood using science.”
In addition, some employees from Scoot will also be participating to determine their own genetic predisposition to travel. More details on the new campaign and how Scoot is helping people fully realize their “Wandermust” nature can be found at www.flyscoot.com/Wandermust
Scoot is the low-cost arm of the Singapore Airlines Group. Scoot took to the skies in June 2012 and merged with Tigerair Singapore in July 2017, retaining the Scoot brand and positioning it well for a new chapter of growth. Scoot has carried over fifty million guests and now operates a fleet of 16 state of the art, widebody Boeing 787 Dreamliners and 24 young and modern Airbus A320 family aircraft, with four more Boeing 787 Dreamliners and 39 Airbus A320neo aircraft on order. Scoot’s network presently encompasses 63 destinations across 17 countries and territories with Berlin, Nanchang, and Pekanbaru to join the network soon. Scoot provides – in addition to fantastic value airfares – a safe, reliable and contemporary travel experience with a unique attitude – Scootitude. Offering amenities including on-board Wi-Fi Internet connectivity and in-seat power on selected flights as well as the ability to redeem and accrue Singapore Airlines KrisFlyer miles, Scoot was voted 2015, 2016, 2017 and 2018 Best Low Cost Airline (Asia/Pacific) by AirlineRatings.com and ranked in the Top 10 of the World’s Best Low-Cost Airlines in 2015 by Skytrax. Scoot is passionate about changing the way people travel long distance. Book your tickets at FlyScoot.com or contact our Call Centre. Find out more on FlyScoot.com, Facebook.com/FlyScoot, Instagram.com/FlyScoot, and Twitter.com/flyscoot.
Source: Read Full Article